Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.900
+0.120 (4.32%)
At close: Mar 9, 2026, 4:00 PM EDT
2.930
+0.030 (1.03%)
After-hours: Mar 9, 2026, 4:23 PM EDT
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $229.73 million as of March 9, 2026. Its market cap has decreased by -11.39% in one year.
Market Cap
229.73M
Enterprise Value
127.92M
1-Year Change
-11.39%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $229.73M, an increase of 414.39%. That is a compound annual growth rate of 20.39%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 239.17M |
| Nuvectis Pharma | 236.44M |
| Alector | 234.52M |
| Cartesian Therapeutics | 233.77M |
| Humacyte | 233.53M |
| Cibus | 233.07M |
| Canton Strategic Holdings | 232.86M |
| Protalix BioTherapeutics | 228.80M |